Hormone therapy use and breast tissue DNA methylation: analysis of epigenome wide data from the normal breast study.
Ontology highlight
ABSTRACT: Hormone therapy (HT) is associated with increased risk of breast cancer, strongly dependent on type, duration, and recency of use. HT use could affect cancer risk by changing breast tissue transcriptional programs. We hypothesize that these changes are preceded by changes in DNA methylation. To explore this hypothesis we used histologically normal-appearing breast tissue from the Normal Breast Study (NBS). DNA methylation β-values were obtained using the Illumina HumanMethylation 450 BeadChips for 90 samples including all NBS-participants who used HT within 5 y before surgery. Data were analyzed using the reference-free cell mixture method. Cancer Genome Atlas (TCGA) mRNA-Seq data were used to assess correlation between DNA methylation and gene expression. We identified 527 CpG sites in 40
SUBMITTER: Harlid S
PROVIDER: S-EPMC6557608 | biostudies-literature | 2019 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA